针对高胆固醇血症管理的七种他类药物中不良事件概况的比较分析,使用美国FDA不良事件报告系统

相关实验视频

Updated: May 10, 2025

09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

14.5K

Toru Ogura¹, Chihiro Shiraishi²

¹Clinical Research Support Center, Mie University Hospital, Tsu, JPN.

Cureus

|April 28, 2025

概括

这项研究发现,用于高胆固醇血症管理的不同类型的他类药物具有独特的不良事件 (AE) 概况. 了解这些独特的AE模式可以帮助医生个性化选择他类药物,以获得更好的患者结果.

科学领域:

药理学药理学是指药理学的学科.
临床药房临床药房
药品安全药品安全

背景情况:

类药物对于管理高胆固醇血症至关重要,目前有七种主要药物可供使用.
尽管有共同的机制,但他类药物在药理动力学和药理动力学特性上有所不同,这影响了它们的安全性.
现有的指导方针缺乏对所有七种他类药物的不良事件 (AE) 概况进行全面比较.

研究的目的:

为了全面比较用于高胆固醇血症的七种他类药物的AE模式和安全性概况.
分析来自美国食品和药物管理局不良事件报告系统 (FAERS) 数据库的数据.
通过只包括患有高胆固醇血症的患者,提供有针对性的比较.

主要方法:

对FAERS数据 (2004-2024) 的回顾性分析.
包括经过记录的高胆固醇血症管理的患者;排除其他患者.
使用报告几率比率 (ROR) 和调整后的ROR (aROR) 与邦费罗尼校正和背景变量调整的比较评估.

主要成果:

作为参考,阿托瓦斯塔丁:五种他类药物在胃肠道疾病中显著提高了ROR和aROR.
五种他类药物在代谢障碍方面显著降低了ROR和aROR.
在他类药物中观察到异质AE模式,表明不同的配置文件.

结论:

在七种他类药物中存在明显的不良事件概况.
这些发现支持个性化治疗策略,通过将患者因子与特定的他类药物AE配置文件对齐.
优化他类药物选择可以改善高胆固醇血管理中的治疗效率和治疗效率.

关键词:

心血管疾病的风险.我们的数据库数据库数据库数据库.药物安全药物安全多次比较,多次比较.个性化医疗是个性化的医疗.药学流行病学药学流行病学

相关概念视频

01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

465

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...

465

01:19

Pharmacovigilance

735

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...

735

01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...

01:12

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...

01:25

Drug Regulation

1.2K

Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...

1.2K

01:29

Cholesterol: Significance and Regulation

457

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...

457